BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 29627482)

  • 1. Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis.
    Habis M; Wroblewski K; Bradaric M; Ismail N; Yamada SD; Litchfield L; Lengyel E; Romero IL
    PLoS One; 2014; 9(8):e104521. PubMed ID: 25118694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany.
    Ihle P; Dippel FW; Schubert I
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00404. PubMed ID: 29760929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic and lipophilic statin use and risk of hearing loss in hyperlipidemia using a Common Data Model: multicenter cohort study.
    Song I; Kim M; Choi H; Kim JH; Lim KH; Yoon HS; Rah YC; Park E; Im GJ; Song JJ; Chae SW; Choi J
    Sci Rep; 2023 Jul; 13(1):12373. PubMed ID: 37524760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting.
    Maumus-Robert S; Jarne-Munoz A; Pariente A; Duroux T; Duranteau L; Bezin J
    Front Endocrinol (Lausanne); 2023; 14():1254221. PubMed ID: 37818086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.
    Chang CH; Kusama M; Ono S; Sugiyama Y; Orii T; Akazawa M
    BMJ Open; 2013; 3(4):. PubMed ID: 23585384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseases.
    Torrandell-Haro G; Branigan GL; Vitali F; Geifman N; Zissimopoulos JM; Brinton RD
    Alzheimers Dement (N Y); 2020; 6(1):e12108. PubMed ID: 33283039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study.
    Miyakoshi A; Ubukata N; Miyake H; Shoji-Asahina A; Dote H; Ohata E; Funaki D; Ichikawa Y; Imaichi Y; Oshima M; Hawke P; Nakatani E
    J Neurooncol; 2024 Jan; 166(2):341-349. PubMed ID: 38206510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
    Kitahara K; Omura J; Wada S; Kim SW
    Pulm Ther; 2024 Mar; 10(1):51-52. PubMed ID: 38123870
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins.
    Danielak D; Karaźniewicz-Łada M; Główka F
    Drugs; 2018 Jul; 78(11):1105-1112. PubMed ID: 30003466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19.
    Shimizu H; Kodama M; Matsumoto M; Orba Y; Sasaki M; Sato A; Sawa H; Nakayama KI
    iScience; 2022 Nov; 25(11):105314. PubMed ID: 36246574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases.
    Mansouri A; Reiner Ž; Ruscica M; Tedeschi-Reiner E; Radbakhsh S; Bagheri Ekta M; Sahebkar A
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.
    Ikuta K; Nakagawa S; Momo K; Yonezawa A; Itohara K; Sato Y; Imai S; Nakagawa T; Matsubara K
    BMJ Open; 2021 Feb; 11(2):e041543. PubMed ID: 33589451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.
    Shidara K; Hoshi D; Inoue E; Yamada T; Nakajima A; Taniguchi A; Hara M; Momohara S; Kamatani N; Yamanaka H
    Mod Rheumatol; 2010 Jun; 20(3):280-6. PubMed ID: 20217173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and the risk of interstitial lung disease: a cohort study.
    Saad N; Camus P; Suissa S; Ernst P
    Thorax; 2013 Apr; 68(4):361-4. PubMed ID: 23299962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].
    Szafrański W
    Pneumonol Alergol Pol; 2012; 80(6):523-32. PubMed ID: 23109204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.
    Fernández AB; Karas RH; Alsheikh-Ali AA; Thompson PD
    Chest; 2008 Oct; 134(4):824-830. PubMed ID: 18689579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of statin-induced interstitial pneumonia in patients treated for hyperlipidemia using a health insurance claims database in Japan.
    Momo K; Takagi A; Miyaji A; Koinuma M
    Pulm Pharmacol Ther; 2018 Jun; 50():88-92. PubMed ID: 29627482
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.